Compositions and methods for treating metabolic disorders
US10201511B2 · kind B2 · utility
7Cited by
24References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 5, 2013 |
| Grant date | Feb 12, 2019 |
| Priority date | — |
| Expiry date | Jan 5, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for improving the gastrointestinal tolerability of biguanide compounds and for treating metabolic disorders and/or inducing weight loss in patients in need thereof, particularly in individuals having a contraindication for treatment with biguanide compounds, are provided comprising administering delayed release formulations of such biguanide compounds, including metformin, targeted to the small intestine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.